Squarepoint’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
+143,687
| New | +$205K | ﹤0.01% | 2336 |
|
|
2024
Q4 | – | Sell |
-147,874
| Closed | -$843K | – | 2802 |
|
|
2024
Q3 | $843K | Buy |
147,874
+90,757
| +159% | +$517K | ﹤0.01% | 1510 |
|
|
2024
Q2 | $264K | Sell |
57,117
-79,710
| -58% | -$368K | ﹤0.01% | 2023 |
|
|
2024
Q1 | $1.12M | Buy |
136,827
+90,802
| +197% | +$742K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $260K | Buy |
+46,025
| New | +$260K | ﹤0.01% | 2017 |
|
|
2023
Q3 | – | Sell |
-52,024
| Closed | -$143K | – | 2500 |
|
|
2023
Q2 | $143K | Sell |
52,024
-55,608
| -52% | -$153K | ﹤0.01% | 2147 |
|
|
2023
Q1 | $338K | Buy |
107,632
+52,911
| +97% | +$166K | ﹤0.01% | 1626 |
|
|
2022
Q4 | $323K | Buy |
54,721
+33,467
| +157% | +$197K | ﹤0.01% | 1660 |
|
|
2022
Q3 | $186K | Sell |
21,254
-15,344
| -42% | -$134K | ﹤0.01% | 1805 |
|
|
2022
Q2 | $276K | Buy |
36,598
+20,519
| +128% | +$155K | ﹤0.01% | 1608 |
|
|
2022
Q1 | $390K | Buy |
16,079
+3,078
| +24% | +$74.7K | ﹤0.01% | 1613 |
|
|
2021
Q4 | $419K | Buy |
+13,001
| New | +$419K | ﹤0.01% | 1697 |
|